LifeStyle
-
Research body sets up venture for beauty products based on maycine extracted from centipede grass
SEOUL -- A bio venture with technology and other support from South Korea's government-funded research body was set up to produce beauty products based on maycine extracted from centipede grass, a popular turfgrass for lawns in warm areas. Maysin and derivatives were found to have various biological activities, but research has been carried out limitedly. Maysin is found in the silks and leaves of maize, teosinte and centipede grass. A team led by Chung Byung-yeoup from the
17 January 2022
-
COVID-19 pandemic harms health of men and increases obesity and drinking
SEOUL -- A prolonged COVID-19 pandemic has harmed the health of men by increasing the prevalence of obesity, hypercholesterolemia, high blood pressure, and high-risk drinking. Obesity was is more pronounced in men than in women, according to a health survey released by South Korea's state health and anti-epidemic center. In a study to analyze changes in public health behaviors and chronic diseases among those over the age of 19, the Korea Disease Control and Prevention Agency (K
31 December 2021
-
Clinical trials of mRNA vaccine candidate to begin in first quarter of 2022
SEOUL -- Clinical trials of a messenger RNA COVID-19 vaccine candidate developed by South Korea's government-sponsored consortium will begin in the first quarter of 2022 if approval comes from a state public health body. The consortium aims to develop mRNA vaccines with preventive effects that are more than equal to those commercialized by Pfizer and Moderna. To develop homemade COVID-19 vaccines, South Korea has launched the so-called K-mRNA consortium involving three drug ma
24 December 2021
-
Researchers develop diagnostic technology to detect Omicron variant in 20 minutes
SEOUL -- South Korean researchers have developed a diagnostic technology that can detect the Omicron variant in 20 minutes. Researchers were able to acquire results in several days, opening the way for health officials to respond quickly even if a new variant occurs. Diagnostic kits can be easily made because professional equipment is not required. A research team led by Lee Jeong-wook, a professor of chemical engineering at Pohang University of Science and Technology (POSTECH), sai
10 December 2021
-
GI Innovation works with Medirama for development of cancer drug candidates
SEOUL -- South Korea's bio-venture company GI Innovation will cooperate with a domestic clinical development and research organization for the development and commercialization of candidate materials for next-generation immuno-cancer drugs. GI Innovation and Medirama will jointly develop two cases of immune-cancer drugs, including GI Innovations's new dual fusion protein, and share profits after commercialization. "New drug candidates to be jointly developed with M
8 December 2021
